De novo overactive bladder following midurethral sling procedures: a systematic review of the literature and meta-analysis

Pergialiotis, Vasilios; Mudiaga, Zini; Perrea, Despina; Doumouchtsis, Stergios K.

doi:10.1007/s00192-017-3417-1

Cited by 35 publications

(37 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the overall rates of de novo UUI are similar to those described previously. 15,23 On the contrary, we have not found the differences in obstructive events observed previously, 15 nor in other complications. However, a higher number of adverse events that could be associated with the material used were observed in the PP group, such as long-term pain, dyspareunia and the need for sling division.…”

Section: Discussioncontrasting

confidence: 87%

Polypropylene and polyvinylidene fluoride transobturator slings for the treatment of female stress urinary incontinence: 1‐Year outcomes from a multicentre randomized trial

Sabadell

Pereda-Núñez

Ojeda-de-Los-Santos

et al. 2020

Neurourology and Urodynamics

View full text Add to dashboard Cite

show abstract

Section: Discussioncontrasting

confidence: 87%

Polypropylene and polyvinylidene fluoride transobturator slings for the treatment of female stress urinary incontinence: 1‐Year outcomes from a multicentre randomized trial

Sabadell

Pereda-Núñez

Ojeda-de-Los-Santos

et al. 2020

Neurourology and Urodynamics

View full text Add to dashboard Cite

show abstract

“…Both methods of sling placement, outside-in and insideout, are safe and have demonstrated curative efficacy in previous studies [11]. However, de novo OAB is reported to develop in 6.4% to 11.5% of patients after the midurethral sling operation [6]. Patients should be informed about their prognosis, because they may continue to experience deteriorated quality of life with different entities of discomfort.…”

Section: Discussionmentioning

confidence: 99%

“…Surgical correction of SUI can improve concurrent overactive bladder (OAB) symptoms such as urgency and UUI [5]. Alternatively, de novo urgency and UUI are observed in some patients with no previous evidence of storage symptoms after anti-incontinence surgery [6]. However, the pathophysiology of improved OAB symptoms in MUI and the risk factors for de novo OAB symptoms after sling operations are unclear [7].…”

Section: Introductionmentioning

confidence: 99%

De novo or resolved urgency and urgency urinary incontinence after midurethral sling operations: How can we properly counsel our patients?

Shin

Choo

2019

Investig Clin Urol

View full text Add to dashboard Cite

Purpose To evaluate de novo and resolved urgency and urgency urinary incontinence (UUI) after midurethral sling operations in patients with stress urinary incontinence (SUI) and mixed urinary incontinence (MUI). Materials and Methods Patients who underwent midurethral sling operations because of SUI and MUI between January 2012 and December 2016 were reviewed. Patients were divided into three groups (pure SUI, SUI with urgency, and MUI). Patients with MUI were subcategorized as SUI predominant, equivalent, and UUI predominant. Postoperative de novo , persistent or disappearance of urgency or UUI were compared. Results A total of 334 patients were included: 76 with pure SUI, 78 with SUI with urgency, and 180 with MUI. In the MUI group, 138 patients were SUI predominant, 12 patients were equivalent, and 30 patients were UUI predominant. De novo urgency developed in 5 patients (6.6%) in the pure SUI group. In the SUI with urgency group, 51 patients (65.4%) became urgency-free, and 3 (3.8%) developed de novo UUI. UUI resolved in 135 patients (75.0%): 110 (79.7%) in the SUI-predominant group, 9 (75.0%) in the equivalent group, and 16 (53.3%) in the UUI-predominant group. The patients' preoperative perception of predominant UUI was the predictive factor for persistent UUI in the multivariate analysis (hazard ratio, 5.722; p=0.001). Conclusions De novo urgency and UUI developed in a relatively small number of patients after a midurethral sling operation. The resolution rate of UUI was significantly low in patients who had previous pelvic surgery or who preoperatively perceived UUI as a more bothersome symptom.

show abstract

“…Another group of special interest is that of patients with persistent OAB and de novo OAB after sling surgery. The overall incidence of de novo OAB following mid-urethral sling procedures ranges between 5% and 22%, while the incidence of persistent urgency reaches 30% [52, 53]. There are limited data on the use of neuromodulation in the management of OAB after sling surgery.…”

Section: Discussionmentioning

confidence: 99%

Neuromodulation - a therapeutic option for refractory overactive bladder. A recent literature review.

Szymański¹,

Słabuszewska-Jóźwiak²,

Zaręba³

et al. 2019

Videosurgery and Other Miniinvasive Techniques

View full text Add to dashboard Cite

Overactive bladder (OAB) affects approximately 17% of the population. The treatment of this clinical condition is challenging, especially when conservative therapy is not effective. There are limited options for the treatment of recurrent OAB. Neuromodulation has taken a significant place in the therapy of recalcitrant lower urinary tract dysfunctions over the past 20 years. The aim of this study was to review the literature evaluating the different forms of neuromodulation in various urological clinical conditions and to show the future prospects of this treatment method. Further studies are necessary to determine the effectiveness of neuromodulation and to identify the prognostic factors of therapeutic success. This could be helpful in the selection of patients who will be most likely to respond positively to the treatment.

show abstract

De novo overactive bladder following midurethral sling procedures: a systematic review of the literature and meta-analysis

Abstract: Current evidence suggests that the overall incidence of de novo OAB following midurethral sling procedures is approximately 9%. There is not enough evidence to support differences in the effects of the different types of sling with regard to this particular postoperative complication.

Cited by 35 publications

References 61 publications

Polypropylene and polyvinylidene fluoride transobturator slings for the treatment of female stress urinary incontinence: 1‐Year outcomes from a multicentre randomized trial

Polypropylene and polyvinylidene fluoride transobturator slings for the treatment of female stress urinary incontinence: 1‐Year outcomes from a multicentre randomized trial

De novo or resolved urgency and urgency urinary incontinence after midurethral sling operations: How can we properly counsel our patients?

Neuromodulation - a therapeutic option for refractory overactive bladder. A recent literature review.

Contact Info

Product

Resources

About